Characterization of CD8- HLA class I/epitope tetrameric complexes binding T cells

Journal of Immunotherapy

Volumn 25, Issue 5, 2002, Pages 379-384

  Nagorsen, Dirk ^a   Monsurrò, Vladia ^a   Wang, Ena ^a   Marincola, Francesco M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

B lymphocytes; HLA; T cell; Tetramer

Indexed keywords

CD19 ANTIGEN; CD27 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; EPITOPE; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA DR ANTIGEN; T LYMPHOCYTE RECEPTOR; TETRAMER;

ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CONTROLLED STUDY; FLOW CYTOMETRY; HELPER CELL; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNIZATION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; STAINING; T LYMPHOCYTE; VACCINATION;

CANCER VACCINES; CASE-CONTROL STUDIES; EPITOPES; HLA ANTIGENS; HUMANS; MACROMOLECULAR SUBSTANCES; MELANOMA; T-LYMPHOCYTE SUBSETS;

EID: 0036733181     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200209000-00001     Document Type: Article

References (16)

1. Smyth MJ, Godfrey DI, Trapani JA. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2001;2:293-9.
2. Altman JD, Moss PH, Goulder PR, et al. Phenotypic analysis of antigen-specific T lymphocytes [published erratum appears in Science 1998;280:1821]. Science 1996;274:94-6.
3. + lymphocytes using class I peptide tetramers. Rev Med Virol 2001;11:11-22.
4. + T cell responses using MHC/peptide tetramers in cancer patients. Int Immunopharmacol 2001;1:1235-47.
5. Keilholz U, Weber J, Finke J, et al. Immunologic monitoring of cancer vaccine therapy: results of a Workshop sponsored by the Society of Biological Therapy. J Immunother 2002;25:97-138.
6. Lanzavecchia A, Iezzi G, Viola A. From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell 1999;96:1-4.
7. + tumor infiltrating lymphocyte. Cancer Res 1999;59:6230-8.
8. Lee K-H, Wang E, Nielsen M-B, et al. Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression. J Immunol 1999;163:6292-6300.
9. Migueles SA, Connors M. Frequency and function of HIV-specific CD8+ T cells. Immunol Lett 2001;79:141-50.
10. Monsurro V, Nielsen M-B, Perez-Diez A, et al. Kinetics of TCR use in response to repeated epitope-specific immunization. J Immunol 2001;166:5817-25.
11. + T cell subsets as a strong adaptive immune response to cytomegolovirus. J Infect Dis 2001;184: 256-67.
12. Speiser DE, Pittet MJ, Valmori D, et al. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lympohcytes. J Exp Med 1999;190:775-82.
13. Szmania S, Galloway A, Bruorton M, et al. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA tetramers. Blood 2001;98:505-12.
14. Loken MR, Shah VO, Dattilio KL, et al. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987;70:1316-24.
15. + T cells. J Exp Med 1997;186:1407-18.
16. Azuma M, Yssel H, Phillips JH, et al. Functional expression of B7-BB1 on activated T lymphocytes. J Exp Med 1993;177: 845-50.